I don’t usually post personal news but Clinicians have told us to pull every lever. Our daughter has with #dipg Brain cancer. There is no cure and typically 9m life expectancy. If anyone knows of trials then please get in contact! #braincancer #childrenscancer Cancer Research UK

BRCA1-BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes biorxiv.org/cgi/content/sh… #bioRxiv

Thanks to Business Weekly newspaper for the article and Kadans Science Partner for the collaboration - we at CHARM Therapeutics are super excited for the move to the Babraham Research Campus Research Campus and continued progress within the company! businessweekly.co.uk/news/biomedtec…

Excited that CHARM Therapeutics are moving to our new home Babraham Research Campus! 🧬🧪🦠🧫🔬 businessweekly.co.uk/news/biomedtec…

Very excited to be travelling to the Microbiology Society Annual Conference in Birmingham this week! A great range of speakers and posters organised for the session on industrial microbiology and green pharma we're leading with the EFB Biotechnology! #Microbio23 microbiologysociety.org/event/annual-c…

Rejoice, after a long time in the making, my latest contribution to the study of DNA repair is finally available for your perusal and scientific scrutiny. Marvel at the fresh new insights we provide into the interactions of the DNA repair factor ERCC6L2. cell.com/cell-reports/f…

Congratulations to the CHARM Therapeutics team on the first publication - Advancing structural biology through breakthroughs in AI. sciencedirect.com/science/articl… #structuralbiology #ai

Great to see our latest paper from CHARM Therapeutics now in print, 'Advancing structural biology through breakthroughs in AI'! authors.elsevier.com/c/1h3ms,LqArQC… #ai #structuralbiology #drugdiscovery

Our new brief note CHARM Therapeutics on AI x Structural Biology is released! We discuss the significance of AlphaFold2 for the field, as well as current limitations and potential future developments. Check it out!⤵️ authors.elsevier.com/c/1h3ms,LqArQC…

Is your institution signed up to #PublishAndRead? Find out about the benefits for authors in participating institutions, including fee-free #OpenAccess publishing: microb.io/2qrGNhy 👈 #Candida2023

Excited to announce our most recent investor at CHARM Therapeutics - NVIDIA's investment arm; NVentures! 🚀🚀🚀 charmtx.com/charm-therapeu…

9th speaker 4 #AIChem23 #AI in #Chemistry Conf RSC BMCS Laksh Aithani/CHARM Therapeutics: #DeepLearning can be used 4 #protein-ligand co-folding (predicting the structure of the protein-ligand complex from the protein sequence & SMILES string of the ligand) rscbmcs.org/events/aichem2…

Excited to see our paper published in #molmicro, demonstrating that the E. coli Lhr helicase is also a uracil-DNA glycosylase! 🧬 Great collaboration from my time at AppSci UHuddersfield with Ed Bolt Uni of Nottingham #WeAreUoN onlinelibrary.wiley.com/doi/10.1111/mm…

Join CHARM Therapeutics's Founder and CEO Laksh at the #IAsummit2023 in Seattle. Laksh will be sharing the stage with an incredible lineup of leaders from startups, big tech, academia, and investing - so do reach out and say Hi!

We are excited to announce the formation of Scientific Advisory Board (SAB) which brings together world-leading experts. Together we are advancing our DragonFold platform, a 3D deep learning technology designed for the discovery and development of small molecule therapeutics. #AI

Planning a nomination for the 2026 Awards? Find out everything you need to know about the nomination process in our useful guidance article, co-written by Colin Bingle and Steve Busby! The Biochemist #BiochemAwards ow.ly/hAV450SSYuM

Engineering Recombinant Proteins for Structural and Functional Studies 2024 will discuss strategies to engineer sufficiently pure, homogenous and high-quality recombinant proteins critical for subsequent studies. Register your place now: ow.ly/Uw1S50T3Omc

Abstract submissions for the 2025 Microbiology Society Annual Conference close soon(12th Nov). Submit your research on microbial warfare (MGEs,HGT, bacteriophage, interference, toxin/anti-toxins, plasmids and more!)Jamie Hall João Botelho Christopher Cooper & Jerry Reen want to hear from you!

With less than 1 month till Advances and New Horizons in Glycobiology, there's still time to secure your place! Celebrating three Biochemical Society Award winners, international research, and networking opportunities, register now #glycotime ow.ly/EBzl50U2nBM

Looking to speaking at the Biochemical Society course on Engineering Recombinant Proteins course in Nottingham today! Great to reconnect with old colleagues and meet new protein afficionados #BiochemEvent